ArticleJACC. Case reports2025
Keeping Up With Carney Complex: A Case of Recurrent Cardiac Myxomas.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCarney complex (CNC) is a rare genetic disorder characterized by endocrine and nonendocrine tumors, including cardiac myxomas, which are a leading cause of mortality due to embolic events, arrhythmias, heart failure, and sudden cardiac death. CASE SUMMARY: We present the case of a 33-year-old man with CNC who experienced stroke-like symptoms due to recurrence of a left atrial myxoma 10 years after initial resection. He underwent successful surgical resection. DISCUSSION: Cardiac myxoma recurrence is higher in patients with CNC, with rates up to 22% compared with 2% to 3% in sporadic cases. This case underscores the importance of lifelong, multidisciplinary care and rigorous surveillance to prevent severe cardiovascular complications. TAKE-HOME MESSAGES: Although rare, it is important to recognize the clinical features and complications of CNC, including the increased risk of recurrent cardiac myxomas. Lifelong cardiac imaging is recommended at 6- to 12-month intervals in patients with CNC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.